FBGKX
Price
$203.85
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
RGAHX
Price
$70.62
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

FBGKX vs RGAHX

Header iconFBGKX vs RGAHX Comparison
Open Charts FBGKX vs RGAHXBanner chart's image
Fidelity Blue Chip Growth K
Price$203.85
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$70.62
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FBGKX vs RGAHX Comparison Chart
Loading...
VS
FBGKX vs. RGAHX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBGKX is a StrongBuy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 284B vs. FBGKX (66.2B). RGAHX pays higher dividends than FBGKX: RGAHX (0.64) vs FBGKX (0.00). FBGKX was incepted earlier than RGAHX: FBGKX (16 years) vs RGAHX (9 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. FBGKX (19.00). FBGKX has a lower initial minimum investment than RGAHX: FBGKX (0) vs RGAHX (250). FBGKX annual gain was more profitable for investors over the last year : 28.49 vs. RGAHX (21.50). FBGKX return over 5 years is better than : 109.38 vs. RGAHX (50.18).
FBGKXRGAHXFBGKX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years9 years-
Gain YTD18.17619.24694%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets66.2B284B23%
Annual Yield % from dividends0.000.64-
Returns for 1 year28.4921.50133%
Returns for 3 years13.83-2.82-491%
Returns for 5 years109.3850.18218%
Returns for 10 years209.60N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INO6.810.18
+2.71%
Inovio Pharmaceuticals
PIPR267.646.57
+2.52%
Piper Sandler Companies
MANH263.74-0.20
-0.08%
Manhattan Associates
ICCT0.50N/A
-0.91%
iCoreConnect
CATX15.10-0.74
-4.67%
Perspective Therapeutics